Researcher from Wenzhou Medical University Discusses Findings in Liver Cancer (Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis)

  • Bin Zhang

    Press/Media: Press / Media

    PeriodMar 17 2023

    Media coverage

    1

    Media coverage

    • TitleResearcher from Wenzhou Medical University Discusses Findings in Liver Cancer (Evaluation of PD-L1 as a biomarker for immunotherapy for hepatocellular carcinoma: systematic review and meta-analysis)
      Media name/outletImmunotherapy Daily
      Country/TerritoryUnited States
      Date03/17/23
      PersonsBin Zhang